+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics

  • ID: 5139503
  • Report
  • September 2020
  • Region: Global
  • 184 pages
  • Global Industry Analysts, Inc
1 of 2
Global ePRO, E-Patient Diaries and eCOA Market to Reach US$3.2 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 14.7% over the period 2020-2027. eCOA, one of the segments analyzed in the report, is projected to grow at a 14.1% CAGR to reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the E-Patient Diaries segment is readjusted to a revised 15.7% CAGR for the next 7-year period. This segment currently accounts for a 37.5% share of the global ePRO, E-Patient Diaries and eCOA market.

The U. S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 14.2% CAGR for the Period of 2020-2027

The ePRO, E-Patient Diaries and eCOA market in the U. S. is estimated at US$366.9 Million in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$566.3 Million in the year 2027 trailing a CAGR of 14.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR while Rest of European market (as defined in the study) will reach US$566.3 Million by the year 2027. We bring years of research experience to this 6th edition of our report. The 184-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • ArisGlobal LLC
  • Bracket Global LLC
  • CRF Health
  • ERT Clinical
  • HealthDiary Inc.
  • ICON PLC
  • Kayentis SAS
  • Medidata Solutions, Inc.
  • OmniComm Systems, Inc.
  • Parexel International Corporation
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • Global Competitor Market Shares
  • ePRO, E-Patient Diaries and eCOA Competitor Market Share Scenario Worldwide (in %): 2018E
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 2: World Historic Review for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 3: World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
  • TABLE 4: World Current & Future Analysis for eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 5: World Historic Review for eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 6: World 15-Year Perspective for eCOA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 7: World Current & Future Analysis for E-Patient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 8: World Historic Review for E-Patient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 9: World 15-Year Perspective for E-Patient Diaries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 10: World Current & Future Analysis for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 11: World Historic Review for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 12: World 15-Year Perspective for Clinical Trial Sponsors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 13: World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 14: World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 15: World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 16: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 18: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 19: World Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 20: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 21: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
  • TABLE 22: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US ePRO, E-Patient Diaries and eCOA Market Share (in %) by Company: 2018 & 2027
  • Market Analytics
  • TABLE 25: USA Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 26: USA Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 27: USA 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 28: USA Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 29: USA Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 30: USA 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
CANADA
  • TABLE 31: Canada Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 32: Canada Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 33: Canada 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 34: Canada Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 35: Canada Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 36: Canada 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
JAPAN
  • TABLE 37: Japan Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 38: Japan Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 39: Japan 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 40: Japan Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 41: Japan Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 42: Japan 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
CHINA
  • TABLE 43: China Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 44: China Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 45: China 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 46: China Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 47: China Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 48: China 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
EUROPE
  • Market Facts & Figures
  • European ePRO, E-Patient Diaries and eCOA Market: Competitor Market Share Scenario (in %) for 2018 & 2027
  • Market Analytics
  • TABLE 49: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2018 through 2027
  • TABLE 50: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 51: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
  • TABLE 52: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 53: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 54: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 55: Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 56: Europe Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 57: Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
FRANCE
  • TABLE 58: France Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 59: France Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 60: France 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 61: France Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 62: France Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 63: France 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
GERMANY
  • TABLE 64: Germany Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 65: Germany Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 66: Germany 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 67: Germany Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 68: Germany Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 69: Germany 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
ITALY
  • TABLE 70: Italy Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 71: Italy Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 72: Italy 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 73: Italy Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 74: Italy Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 75: Italy 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
UNITED KINGDOM
  • TABLE 76: UK Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 77: UK Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 78: UK 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 79: UK Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 80: UK Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 81: UK 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
REST OF EUROPE
  • TABLE 82: Rest of Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 83: Rest of Europe Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 84: Rest of Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 85: Rest of Europe Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 86: Rest of Europe Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 87: Rest of Europe 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
ASIA-PACIFIC
  • TABLE 88: Asia-Pacific Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 89: Asia-Pacific Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 90: Asia-Pacific 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 91: Asia-Pacific Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 92: Asia-Pacific Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 93: Asia-Pacific 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
REST OF WORLD
  • TABLE 94: Rest of World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 95: Rest of World Historic Review for ePRO, E-Patient Diaries and eCOA by Type of Solution - eCOA and E-Patient Diaries Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 96: Rest of World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by Type of Solution - Percentage Breakdown of Value Sales for eCOA and E-Patient Diaries for the Years 2012, 2018 & 2027
  • TABLE 97: Rest of World Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Billion for the Years 2018 through 2027
  • TABLE 98: Rest of World Historic Review for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Billion for Years 2012 through 2017
  • TABLE 99: Rest of World 15-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Sales for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2012, 2018 & 2027
IV. COMPETITION
  • Total Companies Profiled: 32
Note: Product cover images may vary from those shown
Adroll
adroll